New Delhi, April 28 -- India has announced a complete suspension of pharmaceutical exports to Pakistan, effective immediately.

The decision, communicated by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) over the weekend, impacts all categories including Active Pharmaceutical Ingredients (APIs), bulk drugs, and vaccines.

The Directorate General of Foreign Trade (DGFT) has issued an official notification enforcing the ban. Pharmexcil has advised Indian pharmaceutical companies to halt all shipments to Pakistan and refrain from accepting new export orders until further notice.

According to industry officials, India's pharmaceutical exports to Pakistan form a relatively small portion of its global trade portfolio. As a...